Ausgabe 10/2014
Inhalt (28 Artikel)
Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit
Philipp Wohlfarth, Thomas Staudinger, Wolfgang R. Sperr, Andja Bojic, Oliver Robak, Alexander Hermann, Klaus Laczika, Alexander Carlström, Katharina Riss, Werner Rabitsch, Marija Bojic, Paul Knoebl, Gottfried J. Locker, Maria Obiditsch, Valentin Fuhrmann, Peter Schellongowski
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma
Kensuke Takaoka, Yasuhito Nannya, Akihito Shinohara, Shunya Arai, Fumihiko Nakamura, Mineo Kurokawa
Prevalence of anemia among elderly inpatients and its association with multidimensional loss of function
Janek Zilinski, Robert Zillmann, Ingrid Becker, Thomas Benzing, Ralf-Joachim Schulz, Gabriele Roehrig
Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre
Lijun Bai, Wei Xia, Kelly Wong, Cassandra Reid, Christopher Ward, Matthew Greenwood
Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function
Arijit Biswas, Vytautas Ivaskevicius, Anne Thomas, Michael Varvenne, Brigitte Brand, Hannelore Rott, Iris Haussels, Heiko Ruehl, Ute Scholz, Robert Klamroth, Johannes Oldenburg
The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol
Adalet Meral Güneş, Hale Ören, Birol Baytan, Şebnem Yılmaz Bengoa, Melike Sezgin Evim, Salih Gözmen, Özlem Tüfekçi, Tuba Hilkay Karapınar, Gülersu İrken
High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lu, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Xiaoxia Hu, Jianmin Wang
Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1
María Rozman, José-Tomás Navarro, Leonor Arenillas, Anna Aventín, Teresa Giménez, Esther Alonso, Granada Perea, Mireia Camós, Mayda Navarrete, Esperanza Tuset, Lourdes Florensa, Fuensanta Millá, Josep Nomdedéu, Esmeralda de la Banda, Marina Díaz-Beyá, Marta Pratcorona, Ana Garrido, Blanca Navarro, Salut Brunet, Jorge Sierra, Jordi Esteve
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry
Simone Oerlemans, Djamila E. Issa, Esther C. van den Broek, Marten R. Nijziel, Jan Willem W. Coebergh, Peter C. Huijgens, Floortje Mols, Lonneke V. van de Poll-Franse
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
Mathias Witzens-Harig, Robin Foá, Alice Di Rocco, Guy van Hazel, Dalton F. A. Chamone, Jacob M. Rowe, Luca Arcaini, Irina Poddubnaya, Anthony D. Ho, Valentina Ivanova, Andrej Vranovsky, Dan Thurley, Stephan Oertel
Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)—a single region experience on consecutive patients
S. Eketorp Sylvan, J. Lundin, M. Ipek, M. Palma, C. Karlsson, L. Hansson
Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients
Guoqi Song, Ling Gu, Junhong Li, Zhipeng Tang, Hong Liu, Baoan Chen, Xuemei Sun, Bangsun He, Yuqin Pan, Shukui Wang, William C. Cho
ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma
Jorge Labrador, Mónica Cabrero-Calvo, Estefanía Pérez-López, María Victoria Mateos, Lourdes Vázquez, María Dolores Caballero, Ramón García-Sanz
The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab
J. H. Park, D. H. Yoon, D. Y. Kim, S. Kim, S. Seo, Y. Jeong, S. W. Lee, C. S. Park, J. Huh, C. Suh
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Michele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, Dario Ragusa, Pietro Bulian, Davide Rossi, Giovanni Capelli, Francesca Maria Rossi, Pasquale Niscola, Francesco Buccisano, Riccardo Bomben, Antonella Zucchetto, Luca Maurillo, Paolo de Fabritiis, Sergio Amadori, Gianluca Gaidano, Valter Gattei, Giovanni Del Poeta
Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia
Sophie Pöchlauer, Eva Jäger, Ulrich Jäger, Klaus Geissler
Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome
Dron Gauchan, Hamid Shaaban, David Gedeon, Michael Maroules
Dramatic and prompt efficacy of Helicobacter pylori eradication in the treatment of severe refractory iron deficiency anemia in adults
Jun Yamanouchi, Taichi Azuma, Yoshihiro Yakushijin, Takaaki Hato, Masaki Yasukawa
Thromboelastometry changes in myeloproliferative neoplasms—surrogate for a procoagulant haemostatic imbalance or a consequence of technical reasons?
Michael Nagler, Hugo ten Cate
Pneumatosis intestinalis and imatinib mesylate
Ciara O’Rafferty, Fiona McElligott, Lorna Storey, Aengus O’Marcaigh, Owen Smith
The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa
K. T. Htun, J. McFadyen, H. A. Tran
Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1
Maciej Machaczka, Monika Klimkowska
Tandem triplication of the BCL2 gene in CD5-positive intravascular large B cell lymphoma with bone marrow involvement
Katsuya Yamamoto, Atsuo Okamura, Kimikazu Yakushijin, Yoshitake Hayashi, Hiroshi Matsuoka, Hironobu Minami
Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma
Marie Caroline Schlitter, Heiko Rühl, Thore Thiesler, Arndt-Hendrik Penner, Christina Bersens, Dominik Wolf, Karin Mayer
Bortezomib-induced acute congestive heart failure: a case report and review of literature
Ashish Subedi, Lokesh Raj Sharma, Binay Kumar Shah
Independent growth of diffuse large B cell lymphoma and angioimmunoblastic T cell lymphoma originating from composite lymphoma
Rie Tabata, Chiharu Tabata, Ryoji Yasumizu, Masaru Kojima
Refractory lactic acidosis in CD30 positive gastric cancer
Nitipong Permpalung, Nischala Ammannagari, Chrystal D. Price, John A. Fisk, Sara J. Grethlein
Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
Mathias Witzens-Harig, Robin Foá, Alice Di Rocco, Guy van Hazel, Dalton F. A. Chamone, Jacob M. Rowe, Luca Arcaini, Irina Poddubnaya, Anthony D. Ho, Valentina Ivanova, Andrej Vranovsky, Dan Thurley, Stephan Oertel